Pathology Doctors in Findlay, OH Accepting Medicare

4 Pathology doctors found. Showing 1 - 4

Jimmy Sorrells, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 145 W Wallace, Findlay, OH 45840 Phone: 419-423-5324    Fax: 419-423-5125

Heidi Linda Budke, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 145 W Wallace St, Findlay, OH 45840 Phone: 419-423-5112    Fax: 419-423-5125

Darja Praprotnik, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 145 W Wallace St, Findlay, OH 45840 Phone: 419-423-5554    Fax: 419-423-5125

David Y Lai, Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 145 W Wallace St, Findlay, OH 45840 Phone: 419-423-5326    Fax: 419-423-5125

News Archive

Wellington Foods moves to new cGMP compliant manufacturing facility

Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.

Three drug companies to pay $421 million in fraud settlement

Los Angeles Times: Three pharmaceutical firms — Roxane, Abbott Laboratories and B. Braun Medical — "agreed to pay more than $421 million to settle claims of defrauding Medicare and Medicaid — the latest in a string of large healthcare fraud settlements announced by the Justice Department. The drug companies charged one set of prices to doctors and pharmacies but reported another set of inflated figures that were used as benchmarks by government insurers reimbursing healthcare providers, authorities said" (Zajac, 12/8).

Air travel helped spread novel coronavirus in Brazil

Domestic and international air travel helped spread the novel coronavirus in Brazil, a study has found, as tourism bodies push for global travel to resume amid infection resurgences in some countries.

NIH approves BioTime's four GMP human embryonic stem cell lines

BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that four human embryonic stem (hES) cell lines: ESI-035, ESI-049, ESI-051 and ESI-053, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.

Read more Medical News

› Verified 2 days ago